MOREPENLAB vs DRREDDY: Stock Comparison

Head-to-head financial and trading comparison between Morepen Laboratories Limited (MOREPENLAB) and Dr. Reddy's Laboratories Limited (DRREDDY) in the Cross-Sector Peers sector.

MOREPENLAB

NSE: MOREPENLAB
Morepen Laboratories Limited
₹129.55
1Y Return: +213.76%
52W High: ₹146.97
52W Low: ₹41.29
Annual Volatility: 72.31%
Check MOREPENLAB Trade Fees →

DRREDDY

NSE: DRREDDY
Dr. Reddy's Laboratories Limited
₹1,197.00
1Y Return: -2.89%
52W High: ₹1,375.70
52W Low: ₹1,135.60
Annual Volatility: 21.19%
Check DRREDDY Trade Fees →

Key Metrics Comparison Table

MetricMOREPENLABDRREDDYEdge / Winner
Current Market Price (CMP) ₹129.55 ₹1,197.00 —
1-Year Price Return +213.76% -2.89% MOREPENLAB (216.65% higher)
52-Week High ₹146.97 ₹1,375.70 —
52-Week Low ₹41.29 ₹1,135.60 —
30-Day Annualized Volatility 72.31% 21.19% DRREDDY (Steadier)
30-Day Average Daily Volume 21,356,220 1,797,339 MOREPENLAB (Higher Liquidity)
Statutory Cost to Trade ₹1 Lakh ₹118.50 ₹118.50 Identical statutory tariff

Frequently Asked Questions

Between MOREPENLAB and DRREDDY, which stock gave better returns over the last year?

MOREPENLAB has outperformed DRREDDY over the past 12 months with a gain of 213.76% compared to -2.89%.

Which stock is less volatile: MOREPENLAB or DRREDDY?

DRREDDY demonstrated lower price volatility (21.19% annualized) compared to MOREPENLAB (72.31%). Lower volatility generally indicates steadier price action during market downturns.

What is the statutory cost to buy ₹1,00,000 of MOREPENLAB vs DRREDDY?

Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).

Are MOREPENLAB and DRREDDY direct sector competitors?

Yes, both companies operate within the Cross-Sector Peers sector in India and are actively tracked as sector peers by institutional and retail market participants.